AptarGroup (NYSE:ATR) - Aktienkurs, Nachrichten und Analyse

ATR Aktienübersicht

AptarGroup, Inc. entwickelt und fertigt eine Reihe von Lösungen und Dienstleistungen für die Verabreichung von Arzneimitteln, die Abgabe von Konsumgütern und die aktive Materialwissenschaft für die Märkte Pharmazeutik, Schönheitspflege, Körperpflege, Haushaltspflege sowie Lebensmittel und Getränke. Mehr Details

ATR grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	2/6
Künftiges Wachstum	1/6
Vergangene Leistung	5/6
Finanzielle Gesundheit	6/6
Dividenden	4/6

Belohnungen

11.3% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes Gewinnwachstum 7.88% pro Jahr

Die Erträge stiegen im vergangenen Jahr um 19.5%

Risikoanalyse

Signifikante Insiderverkäufe in den letzten 3 Monaten

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WarrenAI

Based on Analyst Price Targets

Aptar's Innovative Expansions And Calculated Alliances Ignite Future Growth Potential

Key Takeaways Strategic acquisitions and facility expansions are set to boost revenue by entering new therapeutic areas and increasing production capacity in key markets. Collaborations and innovative technologies are anticipated to enhance earnings and margins by improving efficiencies, competitiveness, and creating new revenue streams.

View narrative

US$188.00

9.6% undervalued

6.02%

Revenue growth p.a.

1 day ago

AptarGroup, Inc. Wettbewerber

Crown Holdings

NYSE:CCK

US$10.7b

Ball

NYSE:BALL

US$18.0b

Berry Global Group

NYSE:BERY

US$7.9b

Silgan Holdings

NYSE:SLGN

US$5.8b

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für AptarGroup
Historische Aktienkurse
Aktueller Aktienkurs	US$169.88
52-Wochen-Hoch	US$178.03
52-Wochen-Tief	US$122.29
Beta	0.57
11 Monat Veränderung	2.45%
3 Monate Veränderung	12.92%
1 Jahr Veränderung	32.13%
33 Jahre Veränderung	32.53%
5 Jahre Veränderung	50.56%
Veränderung seit IPO	3,384.72%

Aktuelle Nachrichten und Updates

Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching

Nov 14

Are Investors Undervaluing AptarGroup, Inc. (NYSE:ATR) By 46%?

Oct 28

Recent updates

Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching

Nov 14

Are Investors Undervaluing AptarGroup, Inc. (NYSE:ATR) By 46%?

Oct 28

Risks To Shareholder Returns Are Elevated At These Prices For AptarGroup, Inc. (NYSE:ATR)

Oct 14

Return Trends At AptarGroup (NYSE:ATR) Aren't Appealing

Sep 17

Is AptarGroup (NYSE:ATR) A Risky Investment?

Aug 16

AptarGroup, Inc. (NYSE:ATR) Just Released Its Second-Quarter Earnings: Here's What Analysts Think

Jul 31

AptarGroup: Shares Are Pumped Up

Jul 16

AptarGroup (NYSE:ATR) Has Announced That It Will Be Increasing Its Dividend To $0.45

Jul 15

Here's Why Shareholders May Want To Be Cautious With Increasing AptarGroup, Inc.'s (NYSE:ATR) CEO Pay Packet

Apr 25

AptarGroup (NYSE:ATR) Has A Pretty Healthy Balance Sheet

Mar 28

Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching

Mar 07

Risks To Shareholder Returns Are Elevated At These Prices For AptarGroup, Inc. (NYSE:ATR)

Feb 21

AptarGroup, Inc. (NYSE:ATR) Shares Could Be 23% Below Their Intrinsic Value Estimate

Feb 08

AptarGroup (NYSE:ATR) Has More To Do To Multiply In Value Going Forward

Jan 26

AptarGroup: Exceptional Quality, But Priced For Perfection

Jan 18

We Think AptarGroup (NYSE:ATR) Can Stay On Top Of Its Debt

Dec 12

If EPS Growth Is Important To You, AptarGroup (NYSE:ATR) Presents An Opportunity

Nov 29

AptarGroup: The Market Price Has Run Ahead Of Its Performance

Oct 20

Slowing Rates Of Return At AptarGroup (NYSE:ATR) Leave Little Room For Excitement

Sep 22

AptarGroup, Inc. (NYSE:ATR) Shares Could Be 25% Below Their Intrinsic Value Estimate

Sep 07

AptarGroup (NYSE:ATR) Has A Pretty Healthy Balance Sheet

Aug 23

Do AptarGroup's (NYSE:ATR) Earnings Warrant Your Attention?

Aug 03

AptarGroup: There Are Better Prospects Out There

Jul 29

AptarGroup (NYSE:ATR) Will Pay A Larger Dividend Than Last Year At $0.41

Jul 17

A Look At The Fair Value Of AptarGroup, Inc. (NYSE:ATR)

Jun 09

AptarGroup (NYSE:ATR) Has More To Do To Multiply In Value Going Forward

May 25

AptarGroup (NYSE:ATR) Is Paying Out A Dividend Of $0.38

Apr 24

Is AptarGroup (NYSE:ATR) Using Too Much Debt?

Apr 03

AptarGroup Non-GAAP EPS of $0.92 beats by $0.13, revenue of $795.91M beats by $20.34M

Feb 16

Aptar Pharma launches nasal spray pump

Jan 30

AptarGroup: A Solid Business That's Just A Bit Too Pricey

Jan 17

AptarGroup realigns two business reporting segments

Dec 13

AptarGroup (NYSE:ATR) Seems To Use Debt Quite Sensibly

Dec 12

AptarGroup Non-GAAP EPS of $0.95 beats by $0.01, revenue of $836.86M misses by $1.63M

Oct 27

Aktionärsrenditen

	ATR	US Packaging	US Markt
7D	-2.4%	1.4%	-1.0%
1Y	32.1%	27.9%	30.3%

Rendite im Vergleich zur Industrie: ATR übertraf die Branche US Packaging , die im vergangenen Jahr eine Rendite von 27.9 erzielte.

Rendite vs. Markt: ATR übertraf den Markt US, der im vergangenen Jahr eine Rendite von 30.3 erzielte.

Preisvolatilität

Is ATR's price volatile compared to industry and market?
ATR volatility
ATR Average Weekly Movement	2.4%
Packaging Industry Average Movement	3.7%
Market Average Movement	6.2%
10% most volatile stocks in US Market	15.7%
10% least volatile stocks in US Market	3.1%

Stabiler Aktienkurs: ATR hat in den letzten 3 Monaten keine nennenswerten Preisschwankungen aufgewiesen.

Volatilität im Zeitverlauf: ATRDie wöchentliche Volatilität (2%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
1992	13,800	Stephan Tanda	www.aptar.com

Die AptarGroup, Inc. entwickelt und produziert eine Reihe von Lösungen und Dienstleistungen für die Verabreichung von Arzneimitteln, Konsumgütern und aktiven Materialien für die Pharma-, Kosmetik-, Körperpflege-, Haushaltspflege-, Lebensmittel- und Getränkemärkte. Das Unternehmen ist in den Segmenten Aptar Pharma, Aptar Beauty und Aptar Closures tätig. Es bietet auch Pumpen für nasale Allergiebehandlungen und Ventile für Dosierinhalatoren für Atemwegserkrankungen wie Asthma und chronisch obstruktive Lungenerkrankungen, Elastomer für injizierbare Primärverpackungskomponenten und aktive materialwissenschaftliche Lösungen.

AptarGroup, Inc.'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von AptarGroup im Vergleich zum Marktanteil des Unternehmens?
ATR grundlegende Statistiken
Marktanteil	US$11.23b
Gewinn(TTM)	US$335.95m
Umsatz(TTM)	US$3.57b

33.6x

Kurs-Gewinn-Verhältnis

3.2x

Kurs-Umsatz-Verhältnis

Ist ATR zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
ATR Gewinn- und Verlustrechnung (TTM)
Einnahmen	US$3.57b
Kosten der Einnahmen	US$2.23b
Bruttogewinn	US$1.34b
Sonstige Ausgaben	US$1.00b
Umsatz	US$335.95m

Zuletzt gemeldete Gewinne

Sep 30, 2024

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	5.05
Bruttomarge	37.45%
Nettogewinnspanne	9.40%
Schulden/Eigenkapital-Verhältnis	42.0%

Wie hat sich ATR auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

1.1%

Aktuelle Dividendenrendite

33%

Ausschüttungsquote

ATR Aktienübersicht

Belohnungen

Risikoanalyse

Aptar's Innovative Expansions And Calculated Alliances Ignite Future Growth Potential

AptarGroup, Inc. Wettbewerber

NYSE:CCK

US$10.7b

NYSE:BALL

US$18.0b

NYSE:BERY

US$7.9b

NYSE:SLGN

US$5.8b

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching

President of Aptar Beauty recently sold US$673k worth of stock

President notifies of intention to sell stock

Are Investors Undervaluing AptarGroup, Inc. (NYSE:ATR) By 46%?

Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

AptarGroup, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024

Recent updates

Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching

President of Aptar Beauty recently sold US$673k worth of stock

President notifies of intention to sell stock

Are Investors Undervaluing AptarGroup, Inc. (NYSE:ATR) By 46%?

Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

AptarGroup, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024

Price target increased by 8.2% to US$175

Risks To Shareholder Returns Are Elevated At These Prices For AptarGroup, Inc. (NYSE:ATR)

Second quarter dividend of US$0.45 announced

AptarGroup, Inc. (NYSE:ATR) announces an Equity Buyback for $500 million worth of its shares.

Return Trends At AptarGroup (NYSE:ATR) Aren't Appealing

Executive VP & CFO notifies of intention to sell stock

President of Aptar Asia recently sold US$1.1m worth of stock

Is AptarGroup (NYSE:ATR) A Risky Investment?

AptarGroup, Inc. Announces Unidose Liquid System Approves by the U.S. FDA for Allergic Reactions

President notifies of intention to sell stock

AptarGroup, Inc. (NYSE:ATR) Just Released Its Second-Quarter Earnings: Here's What Analysts Think

AptarGroup, Inc. Announces Chief Financial Officer Changes

AptarGroup: Shares Are Pumped Up

AptarGroup (NYSE:ATR) Has Announced That It Will Be Increasing Its Dividend To $0.45

First quarter dividend increased to US$0.45

AptarGroup, Inc. Declares Quarterly Cash Dividend , Payable on August 15, 2024

Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching

Now 21% undervalued after recent price drop

Getting In Cheap On AptarGroup, Inc. (NYSE:ATR) Is Unlikely

Calculating The Intrinsic Value Of AptarGroup, Inc. (NYSE:ATR)

Price target increased by 7.1% to US$159

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Here's Why Shareholders May Want To Be Cautious With Increasing AptarGroup, Inc.'s (NYSE:ATR) CEO Pay Packet

Fourth quarter dividend of US$0.41 announced

AptarGroup, Inc. Declares Quarterly Dividend, Payable on May 16, 2024

Now 20% undervalued

AptarGroup (NYSE:ATR) Has A Pretty Healthy Balance Sheet

Now 21% undervalued

President of Aptar Pharma recently sold US$500k worth of stock

Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching

President notifies of intention to sell stock

Now 20% undervalued

Risks To Shareholder Returns Are Elevated At These Prices For AptarGroup, Inc. (NYSE:ATR)

Full year 2023 earnings: EPS misses analyst expectations

AptarGroup, Inc. (NYSE:ATR) Shares Could Be 23% Below Their Intrinsic Value Estimate

AptarGroup (NYSE:ATR) Has More To Do To Multiply In Value Going Forward

Upcoming dividend of US$0.41 per share at 1.3% yield

AptarGroup, Inc., Annual General Meeting, May 01, 2024

AptarGroup: Exceptional Quality, But Priced For Perfection

Now 21% undervalued after recent price drop

We Think AptarGroup (NYSE:ATR) Can Stay On Top Of Its Debt

If EPS Growth Is Important To You, AptarGroup (NYSE:ATR) Presents An Opportunity

Now 21% undervalued after recent price drop

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

AptarGroup, Inc. Provides Earnings Guidance for the Fourth Quarter of 2023

AptarGroup: The Market Price Has Run Ahead Of Its Performance

Upcoming dividend of US$0.41 per share at 1.3% yield

AptarGroup, Inc. Declares Quarterly Cash Dividend, Payable on November 16, 2023

Slowing Rates Of Return At AptarGroup (NYSE:ATR) Leave Little Room For Excitement

AptarGroup, Inc. (NYSE:ATR) Shares Could Be 25% Below Their Intrinsic Value Estimate

AptarGroup, Inc. Appoints Sarah Glickman to Board of Directors

Independent Director notifies of intention to sell stock

Erträge & Einnahmen